Trial Profile
Modulation of Sympathetic Nerve Activity By Pioglitazone In Type 2 Diabetes Mellitus.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2011
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Jul 2011 New trial record